Dudnyk Advertising & Public Relations Dudnyk is an independently owned, full-service branding, medical marketing and advertising agency founded in 1993; clients include healthcare and pharmaceutical companies, biotech firms, medical device manufacturers, and...
Menzies Consulting, Inc. Menzies Consulting, Inc. is a strategic messaging and online publishing firm providing full-service public relations and marketing solutions to help clients reach their business development and organizational goals.
EmtechBio Emtech Biotechnology Development, Inc. jointly established by Emory University and the Georgia Institute of Technology, converts science to business through translational research and business incubation. Emtech Bio...
BMC Communications BMC Communications Group is a unique health care communications consultancy located in the heart of downtown New York City. BMC was founded in the mid-90's to serve emerging biopharmaceutical and medical device companies...
Brightline Media Brightline is an integrated strategic communications and media consulting firm. Our core focus is helping corporate, health/life science, non-profit, sports, and educational clients define their message, differentiate it...
Vida Communication Vida offers a smart solution to address the communications needs of today's biopharma and healthcare companies. The backbone and advantage of Vida's service is a solid foundation in biotechnology and health science...
Connexon Creative Connexon Creative is a communications company specializing in the fields of science and medicine.
Connexon provides unique services and products that enhance communication between members of the scientific and medical...
Soon after the financial meltdown began late last fall, J. Leslie Glick, Ph.D. (see sidebar on profile of Dr. Glick), who is a staunch supporter of capitalization and free enterprise, proposed the government provide stimulus monies to VC firms to ensure the continued growth and financial stability of the U.S. life sciences industry. In exchange for taxpayer investment in these firms, the federal ...
A Q&A with AstraZeneca CEO David Brennan where he reveals the future of his company, what he's learned on his recent travels, and how the pharma industry must change.
What trends are you seeing in the pharma marketplace as a result of the economic crisis? How is this impacting the debate on health reform in the United States? The pharmaceutical industry is not as exposed to the boom and bust ...
The current financial crisis, increasing global competition, and near patent expiry of several multibillion dollar drugs is fundamentally reshaping the pharmaceutical industry. As consolidation in the industry continues through merger and acquisitions, companies are being forced to examine new strategies to cut costs and improve efficiencies to adapt to new financial realities. To that end, ...
The feasibility of reversing human aging within a matter of decades has traditionally been dismissed by all profes- sional biogerontologists, on the grounds that not only is aging still poorly understood, but also many of those aspects that we do understand are not reversible by any current or foreseeable therapeutic regimen. This broad consensus has recently been challenged by the publica- tion, ...
The highly publicized withdrawal of a number of unsafe drugs from the market over the last several years has led to strong criticism of FDA's ability to protect the public health, resulting in a call for fundamental changes in the United States drug safety system. A report commissioned by FDA in the wake of the Vioxx® withdrawal, and subsequently issued by the Institute of Medicine in 2006, ...
Boaz Mendzelevski, Director of Cardiology at Medifacts International, Inc. continues his investigation into cardiovascular safety in drug development, focusing on drug-induced vascular thrombosis and myocardial ischemia and infarction
Cardiac safety of new drugs in development has recently gained significant momentum due to increased regulatory and public attention. However, while the focus of ...
"Sustaining Performance in State & Local Government" is a white paper summary of an executive dialogue held in Philadelphia, which included a panel of four experts from different levels of government and more than 50 attendees representing numerous government organizations. In it, we tackle how governments can utilize Performance Management principles to do more with less, and how to earn ...
An exclusive interview with Steven Burrill By Cliff Mintz
G. Steven Burrill has devoted his entire career to helping life sciences compa- nies start up operations and sustain their growth. In 1994, he started Burrill & Company — a venture capital (VC), private equity, merchant banking, and media life sciences firm. The Burrill family of life sciences venture capital funds now manages more than ...
The European Commission announced its intention to introduce the most significant re-design of the EU's Pharmacovigilance (PV) system in the last 40 years. Following a recent public consultation, the Commission aims to significantly strengthen and rationalize the system, in order to make it appropriate for an enlarged EU with innovative products, modern information technology and study designs.
Data Migration Best Practices and Recommended Storage System–based Data Migration Techniques White Paper
By Patrick Allaire, Justin Augat, Joe Jose and David Merrill
Executive Summary Forrester 2007 research has shown that in excess of 70 percent of enterprise IT budgets is devoted to maintaining existing infrastructure. Organizations need to accelerate innovation and reduce operating expenses ...
Company descriptions and contact
information are quoted
from the company's website or other promotional information. JAZ'D is not responsible for
the accuracy
of this information. Unless specifically noted, JAZ'D is not sponsored by, affiliated with
or otherwise
connected with any of the listed companies.
